Venture Capital

Updated:

CABIO Biotech (SHG: 688089)

CABIO Biotech (SHG: 688089) is a venture capital firm headquartered in Wuhan, China. The company specializes in producing functional ingredients through...

CABIO Biotech (SHG: 688089)

CABIO Biotech (SHG: 688089) is a venture capital firm headquartered in Wuhan, China. The company specializes in producing functional ingredients through microbial biotechnology. These ingredients are used in human nutrition, animal nutrition, and personal care.

General information

Firm type

Venture Capital

Location

Country

China

City

Wuhan

Corporate office

Wuhan, China

Sector focus

Venture CapitalChina

Frequently asked questions

What type of firm is CABIO Biotech?

CABIO Biotech is a venture capital firm.

Where is CABIO Biotech headquartered?

CABIO Biotech is headquartered in Wuhan, China.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Wuhan Venture Capital profiles